{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:18:59Z","timestamp":1791037139597,"version":"4.1.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Childhood T-cell precursor acute lymphoblastic leukemia (TCP ALL) is an aggressive disease with a presumably short latency that differs in many biologic respects from B-cell precursor (BCP) ALL. We therefore addressed the issue of in utero origin of this particular type of leukemia by tracing oncogenic mutations and clone-specific molecular markers back to birth. These markers included various first- and second-hit genetic alterations (TCRD-LMO2 breakpoint regions, n = 2; TAL1 deletions, n = 3; Notch1 mutations, n = 1) and nononcogenic T-cell receptor rearrangements (n = 13) that were derived from leukemias of 16 children who were 1.5 to 11.2 years old at diagnosis of leukemia. Despite highly sensitive polymerase chain reaction (PCR) approaches (1 cell with a specific marker among 100\u2009000 normal cells), we identified the leukemic clone in the neonatal blood spots in only 1 young child. These data suggest that in contrast to BCP ALL most TCP ALL cases are initiated after birth.<\/jats:p>","DOI":"10.1182\/blood-2007-03-077339","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:58:31Z","timestamp":1181350711000},"page":"3036-3038","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":28,"title":["Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin"],"prefix":"10.1182","volume":"110","author":[{"given":"Susanna","family":"Fischer","sequence":"first","affiliation":[{"name":"Children's Cancer Research Institute (CCRI), St Anna Kinderkrebsforschung, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Mann","sequence":"additional","affiliation":[{"name":"St Anna Kinderspital, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Konrad","sequence":"additional","affiliation":[{"name":"Children's Cancer Research Institute (CCRI), St Anna Kinderkrebsforschung, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Metzler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Erlangen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Ebetsberger","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Landeskinderklinik Linz, Linz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Salzburg, Salzburg, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Nadel","sequence":"additional","affiliation":[{"name":"Centre d'Immunologie de Marseille-Luminy, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM)\u2013Universit\u00e9 de la M\u00e9diterran\u00e9e, Marseille, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Bodamer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar A.","family":"Haas","sequence":"additional","affiliation":[{"name":"St Anna Kinderspital, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Landeskinderklinik Linz, Linz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Renate","family":"Panzer-Gr\u00fcmayer","sequence":"additional","affiliation":[{"name":"Children's Cancer Research Institute (CCRI), St Anna Kinderkrebsforschung, Vienna, Austria;"},{"name":"St Anna Kinderspital, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111713330938900_B1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia.","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"key":"2019111713330938900_B2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","article-title":"Acute lymphoblastic leukemia.","volume":"350","author":"Pui","year":"2004","journal-title":"N Engl J Med"},{"key":"2019111713330938900_B3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrc1880","article-title":"Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.","volume":"6","author":"Grabher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2019111713330938900_B4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.leu.2404481","article-title":"Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies. Report of the BIOMED-2 Concerted Action BHM4 CT98-3936.","volume":"21","author":"Bruggemann","year":"2007","journal-title":"Leukemia"},{"key":"2019111713330938900_B5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.earlhumdev.2004.10.004","article-title":"In utero origins of childhood leukaemia.","volume":"81","author":"Greaves","year":"2005","journal-title":"Early Hum Dev"},{"key":"2019111713330938900_B6","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1182\/blood.V95.8.2722","article-title":"Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia.","volume":"95","author":"Fasching","year":"2000","journal-title":"Blood"},{"key":"2019111713330938900_B7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2002-01-0144","article-title":"Nondisjunction of chromosomes leading to hyperdiploid childhood B-cell precursor acute lymphoblastic leukemia is an early event during leukemogenesis.","volume":"100","author":"Panzer-Grumayer","year":"2002","journal-title":"Blood"},{"key":"2019111713330938900_B8","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood.V99.8.2992","article-title":"High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia.","volume":"99","author":"Taub","year":"2002","journal-title":"Blood"},{"key":"2019111713330938900_B9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1182\/blood.V96.1.264","article-title":"Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia.","volume":"96","author":"Yagi","year":"2000","journal-title":"Blood"},{"key":"2019111713330938900_B10","doi-asserted-by":"crossref","first-page":"15101","DOI":"10.1073\/pnas.222481199","article-title":"Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia.","volume":"99","author":"Wiemels","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713330938900_B11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood.V89.1.281","article-title":"Monoclonal origin of concordant T-cell malignancy in identical twins.","volume":"89","author":"Ford","year":"1997","journal-title":"Blood"},{"key":"2019111713330938900_B12","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1158\/1078-0432.CCR-05-1239","article-title":"Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.","volume":"11","author":"Panzer-Grumayer","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2019111713330938900_B13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.leu.2401245","article-title":"Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.","volume":"13","author":"Pongers-Willemse","year":"1999","journal-title":"Leukemia"},{"key":"2019111713330938900_B14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.leu.2403182","article-title":"High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias.","volume":"18","author":"Hubner","year":"2004","journal-title":"Leukemia"},{"key":"2019111713330938900_B15","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.leu.2404535","article-title":"Optimization of PCR-based minimal residual disease diagnostics for childhood acute lympholbastic leukemia in a multi-center setting.","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia"},{"key":"2019111713330938900_B16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.leu.2403619","article-title":"Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.","volume":"19","author":"Przybylski","year":"2005","journal-title":"Leukemia"},{"key":"2019111713330938900_B17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"2019111713330938900_B18","first-page":"6382","article-title":"scid thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.","volume":"61","author":"Chervinsky","year":"2001","journal-title":"Cancer Res"},{"key":"2019111713330938900_B19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.leu.2401997","article-title":"Development and characterization of T cell leukemia cell lines established from SCL\/LMO1 double transgenic mice.","volume":"15","author":"Chervinsky","year":"2001","journal-title":"Leukemia"},{"key":"2019111713330938900_B20","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1128\/MCB.19.7.5025","article-title":"Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.","volume":"19","author":"Chervinsky","year":"1999","journal-title":"Mol Cell Biol"},{"key":"2019111713330938900_B21","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1073\/pnas.0408708102","article-title":"Cre\/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia.","volume":"102","author":"Langenau","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713330938900_B22","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood-2005-07-3013","article-title":"Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia\/lymphoma.","volume":"107","author":"Lin","year":"2006","journal-title":"Blood"},{"key":"2019111713330938900_B23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood-2005-06-2553","article-title":"Activating Notch1 mutations in mouse models of T-ALL.","volume":"107","author":"O'Neil","year":"2006","journal-title":"Blood"},{"key":"2019111713330938900_B24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"2019111713330938900_B25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-2005-872515","article-title":"Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.","volume":"217","author":"Moricke","year":"2005","journal-title":"Klin Padiatr"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/110\/8\/3036\/1295962\/zh802007003036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/110\/8\/3036\/1295962\/zh802007003036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T13:33:23Z","timestamp":1573997603000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/110\/8\/3036\/23998\/Screening-for-leukemia-and-clonespecific-markers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,15]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,10,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-03-077339","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,15]]}}}